The DOI matches its Crossref record; 405 of the 406 references it cites were found in a registry or an index.
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Open accessAbstract
SUMMARY: The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms. Recent data show that these strains have been detected globally and in many cases are associated with glycopeptide treatment failure; however, more rigorous clinical studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes. It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary. Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections. Given the subtleties of vancomycin susceptibility testing against S. aureus , it is imperative that diagnostic laboratories use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to the difficulties on detecting these strains, vancomycin failures have been increasingly reported in deep-seated infections.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Indeed, S. aureus within the range of susceptibility, with vancomycin MICs > 1 and ≤ 2 μg/ml have been more frequently associated with the hVISA phenotype.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“These global homeostatic changes appear to lead to a reduced autolytic activity with thickened cell wall and an increase amount of free D-Ala-D-Ala dipeptides with less peptidoglycan cross-linking (101, 104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Phenotypically, hVISA/VISA strains exhibit distinct metabolic characteristics that may include i) increase in fructose utilization, ii) increased fatty acid metabolism, iii) impaired acetate metabolism and tricarboxylic acid cycle, iv) decrease in glutamate availability, and iv) increase expression of cell wall synthesis genes.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“As the “resistant” subpopulation is difficult to identify, detection of hVISA becomes very challenging and some S. aureus strains reported as “susceptible” to vancomycin by standard susceptibility testing may still exhibit this phenotype (101).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“In addition, VISA strains bind vancomycin more avidly than their non –VISA counterparts, however, diffusion of the antibiotic molecule into the inner part of the cell wall appears to be impaired.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Finally, a striking feature of many hVISA/VISA strains is the ability to revert from one phenotype to another (or even to a fully vancomycin susceptible phenotype) in the absence of vancomycin exposure.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,018
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,988
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Vandenesch, F., Naimi, T. S., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M. E., et al. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030089 · Cited by 1,718
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
The Changing Epidemiology of Staphylococcus aureus ?
Chambers, H. F. “. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010204 · Cited by 1,419
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Diekema, D. J., Pfaller, M. A., Schmitz, F., Smayevsky, J., Bell, J. M., Jones, R. N., Beach, M. L., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,363
Research works printed but not linked: 1
- Ferraz, V., A. G. Duse, M. Kassel, A. D. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J.90:1113.
Cited by
Sorted by citations
Items 601–700 of 962
Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus
Sirichoat, A., Wongthong, S., Kanyota, R., Tavichakorntrakool, R., Chanawong, A., Welbat, J. U., & Lulitanond, A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.26069 · Cited by 9
Wang, M., Zhai, L., Yu, W., Wei, Y., Wang, L., Liu, S., Li, W., Li, X., Yu, S., Chen, X., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190452 · Cited by 9
Rahimzadeh, G., Gill, P., & Rezai, M. S. (2016) · Australasian Medical Journal · Cited by 9
Mechanisms and Detection of Antimicrobial Resistance
Miller, M. B., & Gilligan, P. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00292-0 · Cited by 8
Butin, M., Claris, O., & Laurent, F. J. (2019) · Archives de Pédiatrie · doi:10.1016/j.arcped.2019.03.002 · Cited by 9
Haas, K., Meyer-Buehn, M., von Both, U., Hübner, J., & Schober, T. (2023) · Infection · doi:10.1007/s15010-023-02036-5 · Cited by 8
Wu, W., Pang, C. N. I., Mediati, D. G., & Tree, J. J. (2024) · mSystems · doi:10.1128/msystems.00971-23 · Cited by 8
Infective endocarditis: Role of molecular techniques in early diagnosis
Albloshi, A. M. K., & Alqumber, M. A. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.060 · Cited by 10
Wu, S., Huang, J., Zhang, F., Zhang, J., Yang, R., Pang, R., Dai, J., Rong, D., Zhao, M., Wang, J., et al. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.06.011 · Cited by 8
A novel fully human recombinant antibody neutralizing α‐hemolysin of Staphylococcus aureus
Xu, W., Peng, L., Li, C., Wu, T., Chen, H., Zhang, H., Yu, H. Z., Ye, Y., Wu, Y., Yuan, Q., et al. (2022) · Apmis · doi:10.1111/apm.13258 · Cited by 8
Moller, A. G., Petit, R. A., Davis, M. H., & Read, T. D. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02728-22 · Cited by 8
Linezolid and vancomycin for nosocomial infections in pediatric patients: a systematic review
Porchera, B. R., da Silva, C. M., Miranda, R. P., Gomes, A. R. Q., Fernandes, P. H. D. S., de Menezes, C. G. O., Laurindo, P. D. S. D. O. D. C., Dolabela, M. F., & Brígido, H. P. C. (2023) · Jornal de Pediatria · doi:10.1016/j.jped.2023.08.011 · Cited by 8
Yu, L., Wang, N., Ma, J., Tong, C., Song, B., Chi, J., Ma, G., Zhu, Z., & Cui, Y. (2013) · Microbiology and Immunology · doi:10.1111/1348-0421.12106 · Cited by 8
Okado, J. B., Bogni, S. C., Reinato, L. A. F., Martínez, R., Gir, E., & Camargo, I. L. B. D. C. (2016) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0284-2015 · Cited by 8
Karki, A., Thurm, C. A., & Cervellione, K. L. (2017) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2017.1374107 · Cited by 8
Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
Lin, C., Wang, J.-H., Lin, K.-H., Ho, Y., & Ho, C. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_145_17 · Cited by 8
Pajares‐Chamorro, N., Wagley, Y., Hammer, N. D., Hankenson, K. D., & Chatzistavrou, X. (2021) · Journal of the American Ceramic Society · doi:10.1111/jace.17923 · Cited by 8
McCallin, S. E., Menzi, C., Lassen, S., Daraspe, J., Oechslin, F., & Moreillon, P. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02247-21 · Cited by 8
Kaur, H., Modgil, V., Chaudhary, N., Mohan, B., & Taneja, N. (2023) · Biomedicines · doi:10.3390/biomedicines11072028 · Cited by 8
Vega, F., Alarcón, P., Domı́nguez, M., Bello‐Toledo, H., Gisela Riedel, M., Mella, S., Aguayo, A., & González-Rocha, G. E. (2015) · Revista chilena de infectología · doi:10.4067/s0716-10182015000600017 · Cited by 8
Davis, R. W., Brannen, A. D., Hossain, J., Monsma, S. A., BOCK, P. E., Nahrendorf, M., Mead, D. A., Lodes, M. J., Liles, M. R., & Panizzi, P. R. (2016) · BMC Genomics · doi:10.1186/s12864-016-2433-8 · Cited by 8
Bakthavatchalam, Y. D., Ramaswamy, B., Janakiraman, R., Steve, R. J., & Veeraraghavan, B. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.05.006 · Cited by 8
Peyrusson, F., Wessem, A. V., Dieppois, G., Françoise Van Bambeke, A., & Tulkens, P. M. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.11.005 · Cited by 8
Liu, Y., Lu, J., Lin, L.-C., Lin, H., & Chen, C. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00134 · Cited by 8
Pathogenesis of Staphylococcus aureus in Humans
Lu, T., & DeLeo, F. R. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch39 · Cited by 8
Huang, V., & Eells, S. J. (2011) · Wiley eBooks · doi:10.1002/9781118063842.ch10 · Cited by 9
Case Commentary: The hidden side of oxacillin resistance in Staphylococcus aureus
Giulieri, S. G. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00716-23 · Cited by 8
Zhou, C., Pawline, M. B., Pironti, A., Morales, S. M., Perault, A. I., Ulrich, R. J., Podkowik, M. M., Lejeune, A., Dumont, A., Stubbe, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.11.593044 · Cited by 11
Ali, L., Karki, S., Boorgula, G. D., Mekakda, A., Cagle-White, B., Bhattarai, S., Beaudoin, R., Blakeney, A., Singh, S. K., Srivastava, S., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00095-25 · Cited by 7
Metabolomics-driven prediction of antibiotic resistance: a perspective on pre-genetic intervention
Hussein, M. H., Creek, D. J., Baker, M. A., Rao, G. G., Li, J., & Velkov, T. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00168-2 · Cited by 7
Ma, J., Liu, W. Y., Wang, B., Yu, S., Yu, L., Song, B., Yu, Y., Zhu, Z., & Cui, Y. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.456 · Cited by 7
Musawi, S. A., Alkhaleefa, Q., Alnassri, S., Alamri, A. M., & Alnimr, A. M. (2021) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2022.63.1.2387 · Cited by 7
Wagner, T. M., Pöntinen, A. K., Rubaye, M. A., Sundsfjord, A., & Hegstad, K. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.12.002 · Cited by 7
Yun, J. H., Chang, E., Bae, S., Jung, J., Kim, M. J., Chong, Y. P., Kim, S., Choi, S., Lee, S., & Kim, Y. S. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00333-24 · Cited by 7
Hotz, J. F., Staudacher, M., Schefberger, K., Spettel, K., Schmid, K., Kriz, R., Schneider, L., Hagemann, J. B., Cyran, N., Schmidt, K., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09797-w · Cited by 7
Awad, S., Alharbi, A. E., & Alshami, I. (2013) · British Journal of Biomedical Science · doi:10.1080/09674845.2013.11669936 · Cited by 8
Sreejisha, M., Shenoy, S. M., Shenoy, S. M., Dhanashree, B., Mahabala, C., & Bhat, G. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s393415 · Cited by 7
Prevalence of multidrug resistant Gram-positive cocci in a Chinese hospital over an 8-year period.
Zhang, R., Wang, F., Kang, J., Wang, X., Yin, D., Dang, W., & Duan, J. (2015) · Europe PMC (PubMed Central) · Cited by 7
Antibiotic Resistance in Staphylococcus Species of Animal Origin
de Souza, M. M. S., Coelho, S. D. M. D. O., Pereira, I. A., Soares, L. D. C., Rocha, B., & Coelho, I. D. S. (2012) · InTech eBooks · doi:10.5772/28518 · Cited by 7
Is Vancomycine Still a Choice for Chronic Osteomyelitis Empirical Therapy in Iran?
Izadi, M., Zamani, M. M., Mousavi, S. A., Sadat, S. M. M., Siami, Z., Ahmadi, N. V., Jafari, N. J., Shirvani, S. M., Fard, M. M., & Fooladi, A. A. I. (2012) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.2165 · Cited by 7
Savini, V., Carretto, E., Polilli, E., Marrollo, R., Santarone, S., Fazii, P., D’Antonio, D., Rossano, A., & Perreten, V. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02861-13 · Cited by 7
Nakamura, J., Yamashiro, H., Miya, H., Nishiguchi, K., Maki, H., & Arimoto, H. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201301074 · Cited by 7
Doddangoudar, V. C., O'Donoghue, M. M., Boost, M. V., Tsang, D. N. C., & Appelbaum, P. C. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq340 · Cited by 7
Antimicrobial stewardship: lessons from human healthcare
Edwards, B., & Gould, I. M. (2012) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.31.1.2107 · Cited by 7
Phillips, C. J., Wisdom, A. J., McKinnon, R. A., Woodman, R. J., & Gordon, D. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0177-7 · Cited by 7
Lee, M. Y., Lee, W. I., Kim, M. H., Kang, S. Y., & Kim, Y. J. (2020) · Current Microbiology · doi:10.1007/s00284-020-02123-y · Cited by 7
Fink, S. L., Martinello, R. A., Campbell, S. M., & Murray, T. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-11 · Cited by 6
Aguglia, E., Chines, E., Stefani, S., & Cafiso, V. (2023) · Antibiotics · doi:10.3390/antibiotics12040783 · Cited by 6
Gul, H., Gul, H., Ahmad, P., Hayat, A., Rehman, M. U., Moussa, I. M., & Elansary, H. O. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1241995 · Cited by 7
Zhao, R., Du, B., Luo, Y., Xue, F., Wang, H., Qu, D., Han, S., Heilbronner, S., & Zhao, Y. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02327-23 · Cited by 7
Lv, J.-X., Huang, Y., Kafauit, F., Wang, Y., Su, C., Ma, J.-H., Xu, Y., Huang, C.-C., Zhang, Q., & Su, Y. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00428-24 · Cited by 6
Małachowa, N., Sturdevant, D. E., Porter, A. R., Martin, G. D., Martens, C., Nair, V., Hansen, B. T., Ricklefs, S., Jenkins, S. G., Chen, L., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00486-24 · Cited by 6
Okolie, C. E., Cockayne, A., Wooldridge, K. G., & James, R. (2014) · Landmark University Repository (Landmark University) · Cited by 6
Non-microbial Natural Products That Inhibit Drug-Resistant Staphylococcus aureus
Chew, J., Peh, S., & Yeang, T. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74588 · Cited by 7
Bacterial heteroresistance: an evolving novel way to combat antibiotics
Manjunath, A., Thumu, S. C. R., Kumar, S., & Halami, P. M. (2021) · Biologia · doi:10.1007/s11756-021-00820-y · Cited by 6
Samanta, I., & Bandyopadhyay, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815770-1.00016-x · Cited by 6
Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria
Monteiro, K. L. C., Silva, O. N., Nascimento, I. J. D. S., Mendonça, F. J. B., Aquino, P. G. V., da Silva‐Júnior, E. F., & de Aquino, T. M. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220321124452 · Cited by 7
Meng, F., Shang, M., Wei, W., Yu, Z., Liu, J., Li, Z., Wang, Z., Wang, J., & Dai, H. (2023) · Antibiotics · doi:10.3390/antibiotics12020323 · Cited by 6
Kohl, M. P., Chane-Woon-Ming, B., Bahena-Ceron, R., Ponce, J. R. J., Antoine, L., Herrgott, L., Romby, P., & Marzi, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3565-0_5 · Cited by 6
Duane, T. M., Capitano, B., Puzniak, L., Biswas, P., & Joshi, M. G. (2013) · Surgical Infections · doi:10.1089/sur.2012.033 · Cited by 6
Contemporary management of prosthetic valve endocarditis: principals and future outlook
O'Connor, C. T., & Kiernan, T. J. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1035648 · Cited by 6
Molecular characterization of vancomycin-intermediate Staphylococcus aureus isolates from Tehran
Peerayeh, S. N., Mirzaee, M., & Behmanesh, M. (2016) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(16)61118-0 · Cited by 6
A glimpse on Staphylococcus aureus translation machinery and its control
Khusainov, I. S., Marenna, A., Cerciat, M., Fechter, P., Hashem, Y., Marzi, S., Romby, P., Yusupova, G. Z., & Yusupov, M. (2016) · Molecular Biology · doi:10.1134/s002689331604004x · Cited by 6
Kim, J. W., Kim, H.-K., Kang, G. S., Kim, I., Kim, H. S., Lee, Y. S., & Yoo, J. I. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0824-2 · Cited by 6
Bakthavatchalam, Y. D., Veeraraghavan, B., Ragupathi, N. K. D., Babu, P., Munuswamy, E., & David, T. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.12.008 · Cited by 6
Martínez-García, S., Chávez-Cabrera, C., Quintana, E. T., Marsch-Moreno, R., Ibáñez-Hernández, M. Á., Zenteno, J. C., Cruz‐Aguilar, M., Velázquez‐Guadarrama, N., Cabrera, G. B., Rodríguez–Martínez, S., et al. (2019) · Indian Journal of Microbiology · doi:10.1007/s12088-019-00800-6 · Cited by 7
Yamaguchi, T., Ando, R., Matsumoto, T., Ishii, Y., & Tateda, K. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s209591 · Cited by 6
Gheorghe, I., Popa, M., & Marutescu, L. G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75191 · Cited by 6
Hassan, M. M., Butler, M. S., Ranzoni, A., & Cooper, M. A. (2019) · Access Microbiology · doi:10.1099/acmi.ac2019.po0201 · Cited by 6
Automating Vancomycin Monitoring to Improve Patient Safety
Mishra, V. K., Chouinard, M., Keiser, J., Wagner, B., Yen, M.-S., Banas, C. A., & Dow, A. W. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2019.07.001 · Cited by 6
Machado, D. P., Goldani, L. Z., Paiva, R. M., Aquino, V. R., de Paris, F., Lisboa, T. C., Jung, B., & dos Santos, R. P. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/585834 · Cited by 6
Zhao, M., Rong, D., Chen, L., Cai, S., Lu, Y., Dai, J., Zhang, Y., Wei, X., Yang, X., & Wu, Q. (2026) · Microorganisms · doi:10.3390/microorganisms14020344 · Cited by 5
NMR and MD Analysis of the Bonding Interaction of Vancomycin with Muramyl Pentapeptide
Ślusarz, R., Dmochowska, B., Samaszko-Fiertek, J., Brzozowski, K., & Madaj, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031146 · Cited by 5
Sustainable Nanomaterials as Promising Antibacterial Agents
El‐Khawaga, A. M., Mukhtar, S., & Shahid, S. (2024) · Sustainable materials and technology · doi:10.1007/978-981-97-2761-2_8 · Cited by 5
Long, D. R., Holmes, E. A., Lo, H.-Y., Penewit, K. M., Almazan, J. D., Hodgson, T., Berger, N. F., Bishop, Z. H., Lewis, J. D., Waalkes, A., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012394 · Cited by 5
Aborah, E., Ayitah, M., Boafo, K. F., Ortiz-Alegria, A., Lekshmi, M., Dhanush, C. K., Kumar, S. H., & Varela, M. F. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100897 · Cited by 5
Nishizawa, M., Djurasovic, M., Glassman, S. D., Crawford, C. H., Dimar, J. R., Owens, R. K., Mathew, J., Kostic, B. A., & Carreon, L. Y. (2025) · The Spine Journal · doi:10.1016/j.spinee.2025.07.029 · Cited by 5
Characterization ofStaphylococcus aureusStrains Isolated from Veterinary Hospital
Stella, A. E., Lima, T., Moreira, C. N., & de Paula, E. M. N. (2020) · International Journal of Microbiology · doi:10.1155/2020/2893027 · Cited by 5
Lamichhane-Khadka, R., Dulal, S., Cuaron, J. A., Pfeltz, R. F., Gupta, S. K., Wilkinson, B. J., & Gustafson, J. E. (2021) · Antibiotics · doi:10.3390/antibiotics10050583 · Cited by 5
Atallah, A., Elbaroody, M., Hassan, A. A., Ali, A. M., & Elhawary, M. E. (2021) · Surgical Neurology International · doi:10.25259/sni_640_2021 · Cited by 5
Kim, Y., Park, J., & Chung, H. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03760-0 · Cited by 5
Jeyachandran, S., & Ragavendran, C. (2024) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-024-05512-6 · Cited by 5
Cao, X., Huang, L. J., Tang, M., Liang, Y., Liu, X., Hou, H., & Liang, S. (2024) · Virulence · doi:10.1080/21505594.2024.2339703 · Cited by 5
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Liapikou, A., Fernández‐Barat, L., & Torres, A. (2012) · Clinical Investigation · doi:10.4155/cli.12.86 · Cited by 5
Arhin, F. F., Sarmiento, I., & Moeck, G. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.004 · Cited by 5
Synthesis, photoluminescent behaviors, and antibacterial activities of 3-acetylcoumarins
Li, M., Li, J., Zhou, Y., Xue, X., Shi, X., Tu, Z.-Y., Hou, Z., & Luo, X. (2013) · Research on Chemical Intermediates · doi:10.1007/s11164-013-1432-5 · Cited by 5
Faghri, J., Shahbazzadeh, D., Bagheri, K. P., Moghim, S., Safaei, H. G., Esfahani, B. N., Fazeli, H., Yazdani, R., & Hamid, M. (2012) · Europe PMC (PubMed Central) · Cited by 5
Haghgoo, S. M., Reza, M. S., & Rafi, A. (2012) · Jentashapir Journal of Health Research · Cited by 5
Heyar, A. K., Gill, A. K., Mahajan, A., & Kaur, K. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/1272 · Cited by 5
Optimization of a small-molecule Lipid II binder
Chauhan, J., Kwasny, S. M., Fletcher, S., Opperman, T. J., & de Leeuw, E. P. H. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.046 · Cited by 5
Chamon, R. C., Marques, L. M., Timenetsky, J., Rachid, C. T. C. D. C., Ferreira, R. B. R., de Oliveira, T. L. R., Glatthardt, T., Moreira, L. D. O., & dos Santos, K. R. N. (2020) · Current Genomics · doi:10.2174/1389202921666200327105756 · Cited by 5
Park, C., Rho, K., Shin, J., Cho, S., Lee, D., & Chung, Y. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0346 · Cited by 5
Kwack, K. H., Lee, J., & Moon, J.-H. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-1425-4 · Cited by 5
Glycopeptide Resistance in S. aureus
Mirza, H. C. (2017) · InTech eBooks · doi:10.5772/65471 · Cited by 4
Muhammad, H. B., Wazir, S. M., & Khan, R. A. (2017) · Studies on Ethno-Medicine · doi:10.1080/09735070.2017.1322368 · Cited by 5
Survivability and Fitness Cost of Heterogeneous Vancomycin-intermediate Staphylococcus aureus
Singh, A. K., Singh, S. K., Singh, J., Rahman, M., Pathak, A. K., & Prasad, K. N. (2017) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_17_311 · Cited by 5
Cornmeal-induced resistance to ciprofloxacin and erythromycin in enterococci
Yu, D., Lai, B.-S., Li, J., Ma, Y., Yang, F., Zhou, L., Luo, X., Chen, X., & Huang, Y. (2012) · Chemosphere · doi:10.1016/j.chemosphere.2012.04.014 · Cited by 5
Luo, H., Knapik, A. A., Petkowski, J. J., Demas, M., Shumilin, I. A., Zheng, H., Chruszcz, M., & Minor, W. (2013) · Journal of Structural and Functional Genomics · doi:10.1007/s10969-013-9158-6 · Cited by 5
Hickok, N. J., Ketonis, C., & Adams, C. S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-055294-1.00126-4 · Cited by 5
Ceftaroline: Potential role and implications in an era of escalating antimicrobial resistance
Chahine, E. B. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100424 · Cited by 5
Metadata
- Authors
- Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L.
- Affiliations
- The University of Melbourne (AU)
- Monash University (AU)
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 23
- Issue
- 1
- Pages
- 99-139
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC2806658
- OpenAlex
- W2126915534
- Cited by
- 962
- References
- 406
- Citations by year
- 2026: 42 · 2025: 41 · 2024: 48 · 2023: 58 · 2022: 45 · 2021: 52 · 2020: 49 · 2019: 60 · 2018: 54 · 2017: 51 · 2016: 63 · 2015: 83 · 2014: 69 · 2013: 88 · 2012: 72
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- vancomycin-intermediate Staphylococcus aureus, heterogeneous vancomycin-intermediate Staphylococcus aureus, reduced vancomycin susceptibility, glycopeptide resistance, cell wall thickening, agr gene, vancomycin susceptibility testing, treatment failure, host-pathogen interaction
- MeSH terms
- Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Treatment Outcome, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
